Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease

Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S91-7. doi: 10.1016/j.jalz.2007.11.012.
No abstract available

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / genetics*
  • Animals
  • Apolipoproteins E / genetics*
  • Brain / enzymology*
  • Clinical Trials as Topic
  • Genetic Predisposition to Disease
  • Genetic Therapy / methods
  • Humans

Substances

  • Apolipoproteins E